SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-010851
Filing Date
2022-05-27
Accepted
2022-05-27 16:00:50
Documents
12
Period of Report
2022-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20220524.htm   iXBRL 8-K 72324
  Complete submission text file 0000950170-22-010851.txt   193814

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20220524_lab.xml EX-101.LAB 13896
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20220524.xsd EX-101.SCH 2452
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20220524_pre.xml EX-101.PRE 11359
6 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20220524_htm.xml XML 4884
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 22977184
SIC: 2834 Pharmaceutical Preparations